Experts are intently observing this treatment, a investigational antibody targeting pathological tau , a significant hallmark of the debilitating disease . Distinct from many past trials focused on https://mtau-9937a039573.pointblog.net/semorinemab-a-emerging-prospect-for-alzheimer-s-disease-94701916